Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8 + T cells

European Journal of Immunology

Volumn 41, Issue 12, 2011, Pages 3513-3528

  Isakov, Dmitry ^a   Dzutsev, Amiran ^a   Berzofsky, Jay A ^a   Belyakov, Igor M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ALPHA ALPHA ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 15; INTERLEUKIN 7; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FEMALE; LAMINA PROPRIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALL INTESTINE; SPLEEN CELL; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; INTESTINE, SMALL; LYMPHOCYTES; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; VACCINIA;

EID: 82255164208     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141453     Document Type: Article

References (89)

1. Guadalupe, M., Reay, E., Sankaran, S., Prindiville, T., Flamm, J., McNeil, A. and Dandekar, S., Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003. 77: 11708-11717.
2. Mehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D. et al., Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004. 200: 761-770.
3. Sui, Y., Zhu, Q., Gagnon, S., Dzutsev, A., Terabe, M., Vaccari, M., Venzon, D. et al., Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc. Natl. Acad. Sci. USA 2010. 107: 9843-9848.
4. Belyakov, I. M. and Berzofsky, J. A., Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 2004. 20: 247-253.
5. Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M. et al., Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998. 280: 427-431.
6. Berzofsky, J. A., Ahlers, J., Janik, J., Morris, J., Oh, S., Terabe, M. and Belyakov, I. M., Progress on new vaccine strategies against chronic viral infections. J. Clin. Invest. 2004. 114: 450-462.
7. Belyakov, I. M., Ahlers, J. D. and Berzofsky, J. A., Mucosal AIDS vaccines: current status and future directions. Expert Rev. Vaccines 2004. 3: 65-73.
8. Belyakov, I. M. and Ahlers, J. D., What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J. Immunol. 2009. 183: 6883-6892.
9. Ahlers, J. D. and Belyakov, I. M., Strategies for optimizing targeting and delivery of mucosal HIV vaccines. Eur. J. Immunol. 2009. 39: 2657-2669.
10. Belyakov, I. M., Ahlers, J. D., Brandwein, B. Y., Earl, P., Kelsall, B. L., Moss, B., Strober, W. and Berzofsky, J. A., The Importance of local mucosal HIV-specific CD8+ cytotoxic T lymphocytes for resistance to mucosal-viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 1998. 102: 2072-2081.
11. Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., Strober, W. and Berzofsky, J. A., Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. USA 1998. 95: 1709-1714.
12. Belyakov, I. M., Ahlers, J. D., Clements, J. D., Strober, W. and Berzofsky, J. A., Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific cytotoxic T lymphocytes. J. Immunol. 2000. 165: 6454-6462.
13. Berzofsky, J. A., Ahlers, J. D. and Belyakov, I. M., Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 2001. 1: 209-219.
14. Pal, R., Venzon, D., Santra, S., Kalyanaraman, V. S., Montefiori, D. C., Hocker, L., Hudacik, L. et al., Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal SHIVKU2 RNA levels. J. Virol. 2006. 80: 3732-3742.
15. Patel, V., Valentin, A., Kulkarni, V., Rosati, M., Bergamaschi, C., Jalah, R., Alicea, C. et al., Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 2010. 28: 4827-4836.
16. Kaufman, D. R., Bivas-Benita, M., Simmons, N. L., Miller, D. and Barouch, D. H., Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+T lymphocytes. J. Virol. 2010. 84: 5986-5996.
17. Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A. and Ahmed, R., Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 2002. 195: 1541-1548.
18. Lodolce, J. P., Burkett, P. R., Boone, D. L., Chien, M. and Ma, A., T cell-independent interleukin 15ralpha signals are required for bystander proliferation. J. Exp. Med. 2001. 194: 1187-1194.
19. Prlic, M., Lefrancois, L. and Jameson, S. C., Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J. Exp. Med. 2002. 195: F49-F52.
20. Geginat, J., Sallusto, F. and Lanzavecchia, A., Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 2001. 194: 1711-1719.
21. Berard, M., Brandt, K., Bulfone-Paus, S. and Tough, D. F., IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J. Immunol. 2003. 170: 5018-5026.
22. Manjunath, N., Shankar, P., Wan, J., Weninger, W., Crowley, M. A., Hieshima, K., Springer, T. A. et al., Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 2001. 108: 871-878.
23. Judge, A. D., Zhang, X., Fujii, H., Surh, C. D. and Sprent, J., Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J. Exp. Med. 2002. 196: 935-946.
24. Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J. and Surh, C. D., Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 2002. 195: 1523-1532.
25. Sato, N., Patel, H. J., Waldmann, T. A. and Tagaya, Y., The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl. Acad. Sci. USA 2007. 104: 588-593.
26. Wu, Z., Xue, H. H., Bernard, J., Zeng, R., Issakov, D., Bollenbacher-Reilley, J., Belyakov, I. M. et al., The IL-15 receptor alpha chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation. Blood 2008. 112: 4411-4419.
27. Roychowdhury, S., May, K. F., Jr., Tzou, K. S., Lin, T., Bhatt, D., Freud, A. G., Guimond, M. et al., Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer Res. 2004. 64: 8062-8067.
28. Ahlers, J. D. and Belyakov, I. M., Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010. 115: 1678-1689.
29. Ahlers, J. D. and Belyakov, I. M., Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS. Trends Immunol. 2010. 31: 120-130.
30. Ahlers, J. D. and Belyakov, I. M., Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol. Med. 2009. 15: 263-274.
31. Wherry, E. J. and Ahmed, R., Memory CD8 T-cell differentiation during viral infection. J. Virol. 2004. 78: 5535-5545.
32. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
33. Masopust, D., Vezys, V., Marzo, A. L. and Lefrancois, L., Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001. 291: 2413-2417.
34. Masopust, D., Vezys, V., Wherry, E. J., Barber, D. L. and Ahmed, R., Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 2006. 176: 2079-2083.
35. Schluns, K. S. and Lefrancois, L., Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 2003. 3: 269-279.
36. Tscharke, D. C., Karupiah, G., Zhou, J., Palmore, T., Irvine, K. R., Haeryfar, S. M., Williams, S. et al., Identification of poxvirus CD8+T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 2005. 201: 95-104.
37. Crawford, F., Kozono, H., White, J., Marrack, P. and Kappler, J., Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 1998. 8: 675-682.
38. Nguyen, L. T., Elford, A. R., Murakami, K., Garza, K. M., Schoenberger, S. P., Odermatt, B., Speiser, D. E. and Ohashi, P. S., Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J. Exp. Med. 2002. 195: 423-435.
39. Goldrath, A. W., Sivakumar, P. V., Glaccum, M., Kennedy, M. K., Bevan, M. J., Benoist, C., Mathis, D. and Butz, E. A., Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J. Exp. Med. 2002. 195: 1515-1522.
40. Laouar, A., Haridas, V., Vargas, D., Zhinan, X., Chaplin, D., van Lier, R. A. and Manjunath, N., CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat. Immunol. 2005. 6: 698-706.
41. Jiang, W., Ferrero, I., Laurenti, E., Trumpp, A. and MacDonald, H. R., c-Myc controls the development of CD8alphaalpha TCRalphabeta intestinal intraepithelial lymphocytes from thymic precursors by regulating IL-15-dependent survival. Blood 2010. 115: 4431-4438.
42. Luckschander, N., Pfammatter, N. S., Sidler, D., Jakob, S., Burgener, I. A., Moore, P. F., Zurbriggen, A. et al., Phenotyping, functional characterization, and developmental changes in canine intestinal intraepithelial lymphocytes. Vet. Res. 2009. 40: 58.
43. Kim, S.-K., Reed, D. S., Heath, W. R., Carbone, F. and Lefrançois, L., Activation and migration of CD8 T cells in the intestinal mucosa1. J. Immunol. 1997. 159: 4295-4306.
44. Wu, M., van Kaer, L., Itohara, S. and Tonegawa, S., Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells. J. Exp. Med. 1991. 174: 213-218.
45. Madakamutil, L. T., Christen, U., Lena, C. J., Wang-Zhu, Y., Attinger, A., Sundarrajan, M., Ellmeier, W. et al., CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science 2004. 304: 590-593.
46. Masopust, D., Choo, D., Vezys, V., Wherry, E. J., Duraiswamy, J., Akondy, R., Wang, J. et al., Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 2010. 207: 553-564.
47. Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R. and Carbone, F. R., Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 2009. 10: 524-530.
48. Belyakov, I. M. and Ahlers, J. D., Functional CD8(+) CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Trends Immunol. 2008. 29: 574-585.
49. Belyakov, I. M., Ahlers, J. D., Nabel, G. J., Moss, B. and Berzofsky, J. A., Generation of functionally active HIV-1 specific CD8(+) CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology 2008. 381: 106-115.
50. Belyakov, I. M. and Ahlers, J. D., Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development. Curr. Top. Microbiol. Immunol. 2011. In press.
51. Belyakov, I. M., Hel, Z., Kelsall, B., Kuznetsov, V. A., Ahlers, J. D., Nacsa, J., Watkins, D., et al., Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 2001. 7: 1320-1326.
52. Belyakov, I. M., Isakov, D., Zhu, Q., Dzutsev, A. and Berzofsky, J. A., A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells. J. Immunol. 2007. 178: 7211-7221.
53. Isakov, D., Dzutsev, A., Belyakov, I. M. and Berzofsky, J. A., Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. Mucosal Immunol. 2009. 2: 450-461.
54. + T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 15154-15159.
55. Waldmann, T. A., Dubois, S. and Tagaya, Y., Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001. 14: 105-110.
56. Burkett, P. R., Koka, R., Chien, M., Chai, S., Chan, F., Ma, A. and Boone, D. L., IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc. Natl. Acad. Sci. USA 2003. 100: 4724-4729.
57. Kunisawa, J., Kurashima, Y., Higuchi, M., Gohda, M., Ishikawa, I., Ogahara, I., Kim, N. et al., Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 2007. 204: 2335-2348.
58. Porter, B. O. and Malek, T. R., IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. J. Immunol. 1999. 163: 5906-5912.
59. Malek, T. R., Levy, R. B., Adkins, B. and He, Y. W., Monoclonal antibodies to the common gamma-chain as cytokine receptor antagonists in vivo: effect on intrathymic and intestinal intraepithelial T lymphocyte development. J. Leukoc. Biol. 1998. 63: 643-649.
60. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N. et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000. 191: 771-780.
61. Kaneko, M., Mizunuma, T., Takimoto, H. and Kumazawa, Y., Development of TCR alpha beta CD8 alpha alpha intestinal intraepithelial lymphocytes is promoted by interleukin-15-producing epithelial cells constitutively stimulated by gram-negative bacteria via TLR4. Biol. Pharm. Bull. 2004. 27: 883-889.
62. Suzuki, H., Duncan, G. S., Takimoto, H. and Mak, T. W., Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 1997. 185: 499-505.
63. Laky, K., Lefrancois, L., Lingenheld, E. G., Ishikawa, H., Lewis, J. M., Olson, S., Suzuki, K. et al., Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J. Exp. Med. 2000. 191: 1569-1580.
64. Ohta, N., Hiroi, T., Kweon, M. N., Kinoshita, N., Jang, M. H., Mashimo, T., Miyazaki, J. and Kiyono, H., IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+T cells for the development of small intestinal inflammation. J. Immunol. 2002. 169: 460-468.
65. Shires, J., Theodoridis, E. and Hayday, A. C., Biological insights into TCRgammadelta+ and TCRalphabeta+intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 2001. 15: 419-434.
66. Dubois, S., Waldmann, T. A. and Muller, J. R., ITK and IL-15 support two distinct subsets of CD8+T cells. Proc. Natl. Acad. Sci. USA 2006. 103: 12075-12080.
67. Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T. M. et al., Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993. 75: 83-97.
68. Ohteki, T., Yoshida, H., Matsuyama, T., Duncan, G. S., Mak, T. W. and Ohashi, P. S., The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+(NK1+T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 1998. 187: 967-972.
69. Huleatt, J. W. and Lefrancois, L., Beta2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment. Immunity 1996. 5: 263-273.
70. Yajima, T., Nishimura, H., Sad, S., Shen, H., Kuwano, H. and Yoshikai, Y., A novel role of IL-15 in early activation of memory CD8+CTL after reinfection. J. Immunol. 2005. 174: 3590-3597.
71. Ahlers, J. D., Belyakov, I. M. and Berzofsky, J. A., Cytokine, chemokine and costimulatory molecule modulation to enhance efficacy of HIV vaccines. Curr. Mol. Med. 2003. 3: 285-301.
72. Ahlers, J. D., Belyakov, I. M., Thomas, E. K. and Berzofsky, J. A., High affinity T-helper epitope induces complementary helper and APC polarization, increased CTL and protection against viral infection. J. Clin. Invest. 2001. 108: 1677-1685.
73. Ahlers, J. D., Belyakov, I. M., Matsui, S. and Berzofsky, J. A., Mechanisms of cytokine synergy essential for vaccine protection against viral challenge. Int. Immunol. 2001. 13: 897-908.
74. Hodge, J. W., Grosenbach, D. W., Rad, A. N., Giuliano, M., Sabzevari, H. and Schlom, J., Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules. Vaccine 2001. 19: 3552-3567.
75. Zhu, Q., Egelston, C., Vivekanandhan, A., Uematsu, S., Akira, S., Klinman, D. M., Belyakov, I. M. and Berzofsky, J. A., Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc. Natl. Acad. Sci. USA 2008. 105: 16260-16265.
76. Zhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M. and Berzofsky, J. A., Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J. Clin. Invest. 2010. 120: 607-616.
77. Staats, H. F., Bradney, C. P., Gwinn, W. M., Jackson, S. S., Sempowski, G. D., Liao, H. X., Letvin, N. L. and Haynes, B. F., Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J. Immunol. 2001. 167: 5386-5394.
78. Ahlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. and Berzofsky, J. A., A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with GM-CSF and CD40L. Proc. Natl. Acad. Sci. USA 2002. 99: 13020-13025.
79. Palazzo, M., Gariboldi, S., Zanobbio, L., Selleri, S., Dusio, G. F., Mauro, V., Rossini, A. et al., Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J. Immunol. 2008. 181: 3126-3136.
80. Ina, K., Kusugami, K., Kawano, Y., Nishiwaki, T., Wen, Z., Musso, A., West, G. A., et al., Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosis. J. Immunol. 2005. 175: 2000-2009.
81. Brunner, T., Arnold, D., Wasem, C., Herren, S. and Frutschi, C., Regulation of cell death and survival in intestinal intraepithelial lymphocytes. Cell Death Differ. 2001. 8: 706-714.
82. Eagle, R. A. and Trowsdale, J., Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 2007. 7: 737-744.
83. Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R. and Raulet, D. H., The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002. 17: 19-29.
84. Dhanji, S. and Teh, H. S., IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. J. Immunol. 2003. 171: 3442-3450.
85. Pardigon, N., Darche, S., Kelsall, B., Bennink, J. R. and Yewdell, J. W., The TL MHC class Ib molecule has only marginal effects on the activation, survival and trafficking of mouse small intestinal intraepithelial lymphocytes. Int. Immunol. 2004. 16: 1305-1313.
86. Mayr, A., Hochstein-Mintzel, V. and Stickl, H., Abstammung, eigenschaften and verwendung des attenuierten vaccinia-stammes MVA. Infection 1975. 3: 6-14.
87. Belyakov, I. M., Wyatt, L. S., Ahlers, J. D., Earl, P., Pendleton, C. D., Kelsall, B. L., Strober, W. et al., Induction of mucosal CTL response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing HIV 89.6 envelope protein. J. Virol. 1998. 72: 8264-8272.
88. Dzutsev, A. H., Belyakov, I. M., Isakov, D. V., Margulies, D. H. and Berzofsky, J. A., Avidity of CD8 T cells sharpens immunodominance. Int. Immunol. 2007. 19: 497-507.
89. Belyakov, I. M., Isakov, D., Zhu, Q., Dzutsev, A., Klinman, D. and Berzofsky, J. A., Enhancement of CD8+ T cell immunity in the lung by CpG ODN increases protective efficacy of a Modified Vaccinia Ankara vaccine against lethal poxvirus infection even in CD4-deficient host. J. Immunol. 2006. 177: 6336-6343.